DD
Insider
Daniel Patrick O'Day
Chairman & CEODaniel Patrick O'Day (Chairman & CEO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $17.3M of GILD (115,640 sh × $150.00, as filed), executed Feb 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
14
0 buys · 14 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$50.1M
shares × price, as filed
Last traded
Sep 1
Filed Sep 2
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $55.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
14 filings
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$2.2M15,000 sh across 3 lots
Exec Sep 1
Filed Sep 2 · 4:12 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.9M
14,400 sh across 2 lots
Exec Aug 3
Filed Aug 4 · 5:40 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.9M
15,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 4:14 PM ET GILDSALE Gilead Sciences, Inc. View filing → $2.0M
15,000 sh across 3 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.3M
10,000 sh across 2 lots
Exec Apr 28
Filed Apr 29 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.4M
10,000 sh × $136.82
Exec Mar 27
Filed Mar 30 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.4M
9,900 sh across 2 lots
Exec Feb 27
Filed Mar 2 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $17.3M
115,640 sh × $150.00
Exec Feb 5
Filed Feb 6 · 5:30 PM ET More filings →